Thermo Fisher Scientific Inc. TMO
NYSE
| 09/26/2026 | 06/27/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.19% | 8.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.19% | 8.99% | |||
| Cost of Revenue | -1.23% | 7.97% | |||
| Gross Profit | 4.68% | 10.49% | |||
| SG&A Expenses | 1.92% | 7.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.61% | 7.85% | |||
| Operating Income | 8.98% | 14.22% | |||
| Income Before Tax | 8.96% | 10.54% | |||
| Income Tax Expenses | 110.78% | 138.57% | |||
| Earnings from Continuing Operations | -0.80% | 5.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -20.00% | 0.00% | |||
| Net Income | -0.86% | 5.15% | |||
| EBIT | 8.98% | 14.22% | |||
| EBITDA | 6.78% | 13.50% | |||
| EPS Basic | -0.59% | 5.43% | |||
| Normalized Basic EPS | 11.51% | 12.03% | |||
| EPS Diluted | -0.84% | 5.63% | |||
| Normalized Diluted EPS | 11.21% | 12.34% | |||
| Average Basic Shares Outstanding | -0.27% | -0.27% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.54% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.00% | 0.03% | |||